GSE199538 GSE199539 enzalutamide 2 v 1 human dn (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GSE199538_GSE199539_enzalutamide_2_v_1_human_dn.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GSE199538_GSE199539_enzalutamide_2_v_1_human_dn.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GSE199538_GSE199539_enzalutamide_2_v_1_human_dn.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GSE199538_GSE199539_enzalutamide_2_v_1_human_dn.

Results found

Linked to

 

Label

Description

 

Gene

synergin gamma

Gene

H3.3 histone A

Gene

SRC kinase signaling inhibitor 1

Gene

general transcription factor IIi pseudogene 4

Gene

FGD5 antisense RNA 1

Gene

metastasis associated lung adenocarcinoma transcript 1

Gene

colorectal neoplasia differentially expressed

Gene

H3 clustered histone 6

Gene

NIPBL divergent transcript

Gene

mir-99a-let-7c cluster host gene



  • Gene

    SRC kinase signaling inhibitor 1


  • Gene

    general transcription factor IIi pseudogene 4


  • Gene

    FGD5 antisense RNA 1


  • Gene

    metastasis associated lung adenocarcinoma transcript 1


  • Gene

    colorectal neoplasia differentially expressed


  • Gene

    H3 clustered histone 6


  • Gene

    NIPBL divergent transcript


  • Gene

    mir-99a-let-7c cluster host gene

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.